The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Point of Care Infectious Disease Testing Market Research Report 2025

Global Point of Care Infectious Disease Testing Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1948379

No of Pages : 91

Synopsis
Infectious disease doctors test your blood or other body fluids to look for specific antibodies — cells produced by our immune system to fight harmful foreign substances. These tests can indicate what kind of infection is present. For bacterial infections, treatment usually involves antibiotics. Launch of mobile & self-testing devices has increased access to testing and monitoring systems to the remote places where the provision of timely medical care is a challenge.
The global Point of Care Infectious Disease Testing market was valued at US$ 2635 million in 2023 and is anticipated to reach US$ 4411.8 million by 2030, witnessing a CAGR of 7.7% during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Point of Care Infectious Disease Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Point of Care Infectious Disease Testing.
Report Scope
The Point of Care Infectious Disease Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Point of Care Infectious Disease Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Point of Care Infectious Disease Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Alere
Thermo Fisher Scientific
F. Hoffmann-La Roche
Siemens Healthineers
BD
Chembio Diagnostics
Trinity Biotech
Cardinal Health
Quest Diagnostics
Bio-Rad Labs
bioMérieux
Sight Diagnostics
Gene POC
Trivitron Healthcare
OJ-Bio
Ortho-Clinical Diagnostics
Segment by Type
HIV POC
HBV POC
Pneumonia or Streptococcus Associated Infections
Respiratory Syncytial Virus (RSV) POC
HPV POC
Influenza POC
Others
Segment by Application
Hospitals
Clinics
Home
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Point of Care Infectious Disease Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Point of Care Infectious Disease Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 HIV POC
1.2.3 HBV POC
1.2.4 Pneumonia or Streptococcus Associated Infections
1.2.5 Respiratory Syncytial Virus (RSV) POC
1.2.6 HPV POC
1.2.7 Influenza POC
1.2.8 Others
1.3 Market by Application
1.3.1 Global Point of Care Infectious Disease Testing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Home
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Point of Care Infectious Disease Testing Market Perspective (2019-2030)
2.2 Point of Care Infectious Disease Testing Growth Trends by Region
2.2.1 Global Point of Care Infectious Disease Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Point of Care Infectious Disease Testing Historic Market Size by Region (2019-2024)
2.2.3 Point of Care Infectious Disease Testing Forecasted Market Size by Region (2025-2030)
2.3 Point of Care Infectious Disease Testing Market Dynamics
2.3.1 Point of Care Infectious Disease Testing Industry Trends
2.3.2 Point of Care Infectious Disease Testing Market Drivers
2.3.3 Point of Care Infectious Disease Testing Market Challenges
2.3.4 Point of Care Infectious Disease Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Point of Care Infectious Disease Testing Players by Revenue
3.1.1 Global Top Point of Care Infectious Disease Testing Players by Revenue (2019-2024)
3.1.2 Global Point of Care Infectious Disease Testing Revenue Market Share by Players (2019-2024)
3.2 Global Point of Care Infectious Disease Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Point of Care Infectious Disease Testing Revenue
3.4 Global Point of Care Infectious Disease Testing Market Concentration Ratio
3.4.1 Global Point of Care Infectious Disease Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Point of Care Infectious Disease Testing Revenue in 2023
3.5 Point of Care Infectious Disease Testing Key Players Head office and Area Served
3.6 Key Players Point of Care Infectious Disease Testing Product Solution and Service
3.7 Date of Enter into Point of Care Infectious Disease Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Point of Care Infectious Disease Testing Breakdown Data by Type
4.1 Global Point of Care Infectious Disease Testing Historic Market Size by Type (2019-2024)
4.2 Global Point of Care Infectious Disease Testing Forecasted Market Size by Type (2025-2030)
5 Point of Care Infectious Disease Testing Breakdown Data by Application
5.1 Global Point of Care Infectious Disease Testing Historic Market Size by Application (2019-2024)
5.2 Global Point of Care Infectious Disease Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Point of Care Infectious Disease Testing Market Size (2019-2030)
6.2 North America Point of Care Infectious Disease Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Point of Care Infectious Disease Testing Market Size by Country (2019-2024)
6.4 North America Point of Care Infectious Disease Testing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Point of Care Infectious Disease Testing Market Size (2019-2030)
7.2 Europe Point of Care Infectious Disease Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Point of Care Infectious Disease Testing Market Size by Country (2019-2024)
7.4 Europe Point of Care Infectious Disease Testing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Point of Care Infectious Disease Testing Market Size (2019-2030)
8.2 Asia-Pacific Point of Care Infectious Disease Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Point of Care Infectious Disease Testing Market Size by Region (2019-2024)
8.4 Asia-Pacific Point of Care Infectious Disease Testing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Point of Care Infectious Disease Testing Market Size (2019-2030)
9.2 Latin America Point of Care Infectious Disease Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Point of Care Infectious Disease Testing Market Size by Country (2019-2024)
9.4 Latin America Point of Care Infectious Disease Testing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Point of Care Infectious Disease Testing Market Size (2019-2030)
10.2 Middle East & Africa Point of Care Infectious Disease Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Point of Care Infectious Disease Testing Market Size by Country (2019-2024)
10.4 Middle East & Africa Point of Care Infectious Disease Testing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Alere
11.1.1 Alere Company Detail
11.1.2 Alere Business Overview
11.1.3 Alere Point of Care Infectious Disease Testing Introduction
11.1.4 Alere Revenue in Point of Care Infectious Disease Testing Business (2019-2024)
11.1.5 Alere Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Detail
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Point of Care Infectious Disease Testing Introduction
11.2.4 Thermo Fisher Scientific Revenue in Point of Care Infectious Disease Testing Business (2019-2024)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 F. Hoffmann-La Roche
11.3.1 F. Hoffmann-La Roche Company Detail
11.3.2 F. Hoffmann-La Roche Business Overview
11.3.3 F. Hoffmann-La Roche Point of Care Infectious Disease Testing Introduction
11.3.4 F. Hoffmann-La Roche Revenue in Point of Care Infectious Disease Testing Business (2019-2024)
11.3.5 F. Hoffmann-La Roche Recent Development
11.4 Siemens Healthineers
11.4.1 Siemens Healthineers Company Detail
11.4.2 Siemens Healthineers Business Overview
11.4.3 Siemens Healthineers Point of Care Infectious Disease Testing Introduction
11.4.4 Siemens Healthineers Revenue in Point of Care Infectious Disease Testing Business (2019-2024)
11.4.5 Siemens Healthineers Recent Development
11.5 BD
11.5.1 BD Company Detail
11.5.2 BD Business Overview
11.5.3 BD Point of Care Infectious Disease Testing Introduction
11.5.4 BD Revenue in Point of Care Infectious Disease Testing Business (2019-2024)
11.5.5 BD Recent Development
11.6 Chembio Diagnostics
11.6.1 Chembio Diagnostics Company Detail
11.6.2 Chembio Diagnostics Business Overview
11.6.3 Chembio Diagnostics Point of Care Infectious Disease Testing Introduction
11.6.4 Chembio Diagnostics Revenue in Point of Care Infectious Disease Testing Business (2019-2024)
11.6.5 Chembio Diagnostics Recent Development
11.7 Trinity Biotech
11.7.1 Trinity Biotech Company Detail
11.7.2 Trinity Biotech Business Overview
11.7.3 Trinity Biotech Point of Care Infectious Disease Testing Introduction
11.7.4 Trinity Biotech Revenue in Point of Care Infectious Disease Testing Business (2019-2024)
11.7.5 Trinity Biotech Recent Development
11.8 Cardinal Health
11.8.1 Cardinal Health Company Detail
11.8.2 Cardinal Health Business Overview
11.8.3 Cardinal Health Point of Care Infectious Disease Testing Introduction
11.8.4 Cardinal Health Revenue in Point of Care Infectious Disease Testing Business (2019-2024)
11.8.5 Cardinal Health Recent Development
11.9 Quest Diagnostics
11.9.1 Quest Diagnostics Company Detail
11.9.2 Quest Diagnostics Business Overview
11.9.3 Quest Diagnostics Point of Care Infectious Disease Testing Introduction
11.9.4 Quest Diagnostics Revenue in Point of Care Infectious Disease Testing Business (2019-2024)
11.9.5 Quest Diagnostics Recent Development
11.10 Bio-Rad Labs
11.10.1 Bio-Rad Labs Company Detail
11.10.2 Bio-Rad Labs Business Overview
11.10.3 Bio-Rad Labs Point of Care Infectious Disease Testing Introduction
11.10.4 Bio-Rad Labs Revenue in Point of Care Infectious Disease Testing Business (2019-2024)
11.10.5 Bio-Rad Labs Recent Development
11.11 bioMérieux
11.11.1 bioMérieux Company Detail
11.11.2 bioMérieux Business Overview
11.11.3 bioMérieux Point of Care Infectious Disease Testing Introduction
11.11.4 bioMérieux Revenue in Point of Care Infectious Disease Testing Business (2019-2024)
11.11.5 bioMérieux Recent Development
11.12 Sight Diagnostics
11.12.1 Sight Diagnostics Company Detail
11.12.2 Sight Diagnostics Business Overview
11.12.3 Sight Diagnostics Point of Care Infectious Disease Testing Introduction
11.12.4 Sight Diagnostics Revenue in Point of Care Infectious Disease Testing Business (2019-2024)
11.12.5 Sight Diagnostics Recent Development
11.13 Gene POC
11.13.1 Gene POC Company Detail
11.13.2 Gene POC Business Overview
11.13.3 Gene POC Point of Care Infectious Disease Testing Introduction
11.13.4 Gene POC Revenue in Point of Care Infectious Disease Testing Business (2019-2024)
11.13.5 Gene POC Recent Development
11.14 Trivitron Healthcare
11.14.1 Trivitron Healthcare Company Detail
11.14.2 Trivitron Healthcare Business Overview
11.14.3 Trivitron Healthcare Point of Care Infectious Disease Testing Introduction
11.14.4 Trivitron Healthcare Revenue in Point of Care Infectious Disease Testing Business (2019-2024)
11.14.5 Trivitron Healthcare Recent Development
11.15 OJ-Bio
11.15.1 OJ-Bio Company Detail
11.15.2 OJ-Bio Business Overview
11.15.3 OJ-Bio Point of Care Infectious Disease Testing Introduction
11.15.4 OJ-Bio Revenue in Point of Care Infectious Disease Testing Business (2019-2024)
11.15.5 OJ-Bio Recent Development
11.16 Ortho-Clinical Diagnostics
11.16.1 Ortho-Clinical Diagnostics Company Detail
11.16.2 Ortho-Clinical Diagnostics Business Overview
11.16.3 Ortho-Clinical Diagnostics Point of Care Infectious Disease Testing Introduction
11.16.4 Ortho-Clinical Diagnostics Revenue in Point of Care Infectious Disease Testing Business (2019-2024)
11.16.5 Ortho-Clinical Diagnostics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
List of Tables
Table 1. Global Point of Care Infectious Disease Testing Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of HIV POC
Table 3. Key Players of HBV POC
Table 4. Key Players of Pneumonia or Streptococcus Associated Infections
Table 5. Key Players of Respiratory Syncytial Virus (RSV) POC
Table 6. Key Players of HPV POC
Table 7. Key Players of Influenza POC
Table 8. Key Players of Others
Table 9. Global Point of Care Infectious Disease Testing Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 10. Global Point of Care Infectious Disease Testing Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 11. Global Point of Care Infectious Disease Testing Market Size by Region (2019-2024) & (US$ Million)
Table 12. Global Point of Care Infectious Disease Testing Market Share by Region (2019-2024)
Table 13. Global Point of Care Infectious Disease Testing Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 14. Global Point of Care Infectious Disease Testing Market Share by Region (2025-2030)
Table 15. Point of Care Infectious Disease Testing Market Trends
Table 16. Point of Care Infectious Disease Testing Market Drivers
Table 17. Point of Care Infectious Disease Testing Market Challenges
Table 18. Point of Care Infectious Disease Testing Market Restraints
Table 19. Global Point of Care Infectious Disease Testing Revenue by Players (2019-2024) & (US$ Million)
Table 20. Global Point of Care Infectious Disease Testing Market Share by Players (2019-2024)
Table 21. Global Top Point of Care Infectious Disease Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Point of Care Infectious Disease Testing as of 2023)
Table 22. Ranking of Global Top Point of Care Infectious Disease Testing Companies by Revenue (US$ Million) in 2023
Table 23. Global 5 Largest Players Market Share by Point of Care Infectious Disease Testing Revenue (CR5 and HHI) & (2019-2024)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Point of Care Infectious Disease Testing Product Solution and Service
Table 26. Date of Enter into Point of Care Infectious Disease Testing Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Point of Care Infectious Disease Testing Market Size by Type (2019-2024) & (US$ Million)
Table 29. Global Point of Care Infectious Disease Testing Revenue Market Share by Type (2019-2024)
Table 30. Global Point of Care Infectious Disease Testing Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 31. Global Point of Care Infectious Disease Testing Revenue Market Share by Type (2025-2030)
Table 32. Global Point of Care Infectious Disease Testing Market Size by Application (2019-2024) & (US$ Million)
Table 33. Global Point of Care Infectious Disease Testing Revenue Market Share by Application (2019-2024)
Table 34. Global Point of Care Infectious Disease Testing Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 35. Global Point of Care Infectious Disease Testing Revenue Market Share by Application (2025-2030)
Table 36. North America Point of Care Infectious Disease Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. North America Point of Care Infectious Disease Testing Market Size by Country (2019-2024) & (US$ Million)
Table 38. North America Point of Care Infectious Disease Testing Market Size by Country (2025-2030) & (US$ Million)
Table 39. Europe Point of Care Infectious Disease Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 40. Europe Point of Care Infectious Disease Testing Market Size by Country (2019-2024) & (US$ Million)
Table 41. Europe Point of Care Infectious Disease Testing Market Size by Country (2025-2030) & (US$ Million)
Table 42. Asia-Pacific Point of Care Infectious Disease Testing Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 43. Asia-Pacific Point of Care Infectious Disease Testing Market Size by Region (2019-2024) & (US$ Million)
Table 44. Asia-Pacific Point of Care Infectious Disease Testing Market Size by Region (2025-2030) & (US$ Million)
Table 45. Latin America Point of Care Infectious Disease Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Latin America Point of Care Infectious Disease Testing Market Size by Country (2019-2024) & (US$ Million)
Table 47. Latin America Point of Care Infectious Disease Testing Market Size by Country (2025-2030) & (US$ Million)
Table 48. Middle East & Africa Point of Care Infectious Disease Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 49. Middle East & Africa Point of Care Infectious Disease Testing Market Size by Country (2019-2024) & (US$ Million)
Table 50. Middle East & Africa Point of Care Infectious Disease Testing Market Size by Country (2025-2030) & (US$ Million)
Table 51. Alere Company Detail
Table 52. Alere Business Overview
Table 53. Alere Point of Care Infectious Disease Testing Product
Table 54. Alere Revenue in Point of Care Infectious Disease Testing Business (2019-2024) & (US$ Million)
Table 55. Alere Recent Development
Table 56. Thermo Fisher Scientific Company Detail
Table 57. Thermo Fisher Scientific Business Overview
Table 58. Thermo Fisher Scientific Point of Care Infectious Disease Testing Product
Table 59. Thermo Fisher Scientific Revenue in Point of Care Infectious Disease Testing Business (2019-2024) & (US$ Million)
Table 60. Thermo Fisher Scientific Recent Development
Table 61. F. Hoffmann-La Roche Company Detail
Table 62. F. Hoffmann-La Roche Business Overview
Table 63. F. Hoffmann-La Roche Point of Care Infectious Disease Testing Product
Table 64. F. Hoffmann-La Roche Revenue in Point of Care Infectious Disease Testing Business (2019-2024) & (US$ Million)
Table 65. F. Hoffmann-La Roche Recent Development
Table 66. Siemens Healthineers Company Detail
Table 67. Siemens Healthineers Business Overview
Table 68. Siemens Healthineers Point of Care Infectious Disease Testing Product
Table 69. Siemens Healthineers Revenue in Point of Care Infectious Disease Testing Business (2019-2024) & (US$ Million)
Table 70. Siemens Healthineers Recent Development
Table 71. BD Company Detail
Table 72. BD Business Overview
Table 73. BD Point of Care Infectious Disease Testing Product
Table 74. BD Revenue in Point of Care Infectious Disease Testing Business (2019-2024) & (US$ Million)
Table 75. BD Recent Development
Table 76. Chembio Diagnostics Company Detail
Table 77. Chembio Diagnostics Business Overview
Table 78. Chembio Diagnostics Point of Care Infectious Disease Testing Product
Table 79. Chembio Diagnostics Revenue in Point of Care Infectious Disease Testing Business (2019-2024) & (US$ Million)
Table 80. Chembio Diagnostics Recent Development
Table 81. Trinity Biotech Company Detail
Table 82. Trinity Biotech Business Overview
Table 83. Trinity Biotech Point of Care Infectious Disease Testing Product
Table 84. Trinity Biotech Revenue in Point of Care Infectious Disease Testing Business (2019-2024) & (US$ Million)
Table 85. Trinity Biotech Recent Development
Table 86. Cardinal Health Company Detail
Table 87. Cardinal Health Business Overview
Table 88. Cardinal Health Point of Care Infectious Disease Testing Product
Table 89. Cardinal Health Revenue in Point of Care Infectious Disease Testing Business (2019-2024) & (US$ Million)
Table 90. Cardinal Health Recent Development
Table 91. Quest Diagnostics Company Detail
Table 92. Quest Diagnostics Business Overview
Table 93. Quest Diagnostics Point of Care Infectious Disease Testing Product
Table 94. Quest Diagnostics Revenue in Point of Care Infectious Disease Testing Business (2019-2024) & (US$ Million)
Table 95. Quest Diagnostics Recent Development
Table 96. Bio-Rad Labs Company Detail
Table 97. Bio-Rad Labs Business Overview
Table 98. Bio-Rad Labs Point of Care Infectious Disease Testing Product
Table 99. Bio-Rad Labs Revenue in Point of Care Infectious Disease Testing Business (2019-2024) & (US$ Million)
Table 100. Bio-Rad Labs Recent Development
Table 101. bioMérieux Company Detail
Table 102. bioMérieux Business Overview
Table 103. bioMérieux Point of Care Infectious Disease Testing Product
Table 104. bioMérieux Revenue in Point of Care Infectious Disease Testing Business (2019-2024) & (US$ Million)
Table 105. bioMérieux Recent Development
Table 106. Sight Diagnostics Company Detail
Table 107. Sight Diagnostics Business Overview
Table 108. Sight Diagnostics Point of Care Infectious Disease Testing Product
Table 109. Sight Diagnostics Revenue in Point of Care Infectious Disease Testing Business (2019-2024) & (US$ Million)
Table 110. Sight Diagnostics Recent Development
Table 111. Gene POC Company Detail
Table 112. Gene POC Business Overview
Table 113. Gene POC Point of Care Infectious Disease Testing Product
Table 114. Gene POC Revenue in Point of Care Infectious Disease Testing Business (2019-2024) & (US$ Million)
Table 115. Gene POC Recent Development
Table 116. Trivitron Healthcare Company Detail
Table 117. Trivitron Healthcare Business Overview
Table 118. Trivitron Healthcare Point of Care Infectious Disease Testing Product
Table 119. Trivitron Healthcare Revenue in Point of Care Infectious Disease Testing Business (2019-2024) & (US$ Million)
Table 120. Trivitron Healthcare Recent Development
Table 121. OJ-Bio Company Detail
Table 122. OJ-Bio Business Overview
Table 123. OJ-Bio Point of Care Infectious Disease Testing Product
Table 124. OJ-Bio Revenue in Point of Care Infectious Disease Testing Business (2019-2024) & (US$ Million)
Table 125. OJ-Bio Recent Development
Table 126. Ortho-Clinical Diagnostics Company Detail
Table 127. Ortho-Clinical Diagnostics Business Overview
Table 128. Ortho-Clinical Diagnostics Point of Care Infectious Disease Testing Product
Table 129. Ortho-Clinical Diagnostics Revenue in Point of Care Infectious Disease Testing Business (2019-2024) & (US$ Million)
Table 130. Ortho-Clinical Diagnostics Recent Development
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Point of Care Infectious Disease Testing Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Point of Care Infectious Disease Testing Market Share by Type: 2023 VS 2030
Figure 3. HIV POC Features
Figure 4. HBV POC Features
Figure 5. Pneumonia or Streptococcus Associated Infections Features
Figure 6. Respiratory Syncytial Virus (RSV) POC Features
Figure 7. HPV POC Features
Figure 8. Influenza POC Features
Figure 9. Others Features
Figure 10. Global Point of Care Infectious Disease Testing Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 11. Global Point of Care Infectious Disease Testing Market Share by Application: 2023 VS 2030
Figure 12. Hospitals Case Studies
Figure 13. Clinics Case Studies
Figure 14. Home Case Studies
Figure 15. Others Case Studies
Figure 16. Point of Care Infectious Disease Testing Report Years Considered
Figure 17. Global Point of Care Infectious Disease Testing Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 18. Global Point of Care Infectious Disease Testing Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 19. Global Point of Care Infectious Disease Testing Market Share by Region: 2023 VS 2030
Figure 20. Global Point of Care Infectious Disease Testing Market Share by Players in 2023
Figure 21. Global Top Point of Care Infectious Disease Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Point of Care Infectious Disease Testing as of 2023)
Figure 22. The Top 10 and 5 Players Market Share by Point of Care Infectious Disease Testing Revenue in 2023
Figure 23. North America Point of Care Infectious Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. North America Point of Care Infectious Disease Testing Market Share by Country (2019-2030)
Figure 25. United States Point of Care Infectious Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Canada Point of Care Infectious Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Europe Point of Care Infectious Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Europe Point of Care Infectious Disease Testing Market Share by Country (2019-2030)
Figure 29. Germany Point of Care Infectious Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. France Point of Care Infectious Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. U.K. Point of Care Infectious Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Italy Point of Care Infectious Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Russia Point of Care Infectious Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Nordic Countries Point of Care Infectious Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Asia-Pacific Point of Care Infectious Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Asia-Pacific Point of Care Infectious Disease Testing Market Share by Region (2019-2030)
Figure 37. China Point of Care Infectious Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Japan Point of Care Infectious Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. South Korea Point of Care Infectious Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Southeast Asia Point of Care Infectious Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. India Point of Care Infectious Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Australia Point of Care Infectious Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Latin America Point of Care Infectious Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Latin America Point of Care Infectious Disease Testing Market Share by Country (2019-2030)
Figure 45. Mexico Point of Care Infectious Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Brazil Point of Care Infectious Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Point of Care Infectious Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Point of Care Infectious Disease Testing Market Share by Country (2019-2030)
Figure 49. Turkey Point of Care Infectious Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia Point of Care Infectious Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 51. Alere Revenue Growth Rate in Point of Care Infectious Disease Testing Business (2019-2024)
Figure 52. Thermo Fisher Scientific Revenue Growth Rate in Point of Care Infectious Disease Testing Business (2019-2024)
Figure 53. F. Hoffmann-La Roche Revenue Growth Rate in Point of Care Infectious Disease Testing Business (2019-2024)
Figure 54. Siemens Healthineers Revenue Growth Rate in Point of Care Infectious Disease Testing Business (2019-2024)
Figure 55. BD Revenue Growth Rate in Point of Care Infectious Disease Testing Business (2019-2024)
Figure 56. Chembio Diagnostics Revenue Growth Rate in Point of Care Infectious Disease Testing Business (2019-2024)
Figure 57. Trinity Biotech Revenue Growth Rate in Point of Care Infectious Disease Testing Business (2019-2024)
Figure 58. Cardinal Health Revenue Growth Rate in Point of Care Infectious Disease Testing Business (2019-2024)
Figure 59. Quest Diagnostics Revenue Growth Rate in Point of Care Infectious Disease Testing Business (2019-2024)
Figure 60. Bio-Rad Labs Revenue Growth Rate in Point of Care Infectious Disease Testing Business (2019-2024)
Figure 61. bioMérieux Revenue Growth Rate in Point of Care Infectious Disease Testing Business (2019-2024)
Figure 62. Sight Diagnostics Revenue Growth Rate in Point of Care Infectious Disease Testing Business (2019-2024)
Figure 63. Gene POC Revenue Growth Rate in Point of Care Infectious Disease Testing Business (2019-2024)
Figure 64. Trivitron Healthcare Revenue Growth Rate in Point of Care Infectious Disease Testing Business (2019-2024)
Figure 65. OJ-Bio Revenue Growth Rate in Point of Care Infectious Disease Testing Business (2019-2024)
Figure 66. Ortho-Clinical Diagnostics Revenue Growth Rate in Point of Care Infectious Disease Testing Business (2019-2024)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’